Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8420629 Azetidine and cyclobutane derivatives as JAK inhibitors

Patent 8420629 was granted and assigned to Incyte on April, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Stacey Shepard0

James D. Rodgers0

Date of Patent

April 16, 2013

Patent Application Number

13315750

Date Filed

December 9, 2011

Patent Citations Received

US Patent 12071439 Process and intermediates for preparing a JAK inhibitor

0

US Patent 11744832 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as Janus kinase inhibitors

US Patent 11833155 Combination therapy for treatment of myeloproliferative neoplasms

0

US Patent 11851442 Tricyclic fused thiophene derivatives as JAK inhibitors

0

US Patent 11905292 Process and intermediates for preparing a JAK inhibitor

0

Patent Primary Examiner

Patent abstract

The present invention relates to azetidine and cyclobutane derivatives, as well as their compositions, methods of use, and processes for preparation, which are JAK inhibitors useful in the treatment of JAK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8420629 Azetidine and cyclobutane derivatives as JAK inhibitors

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.